Notes - Segment Information, Etc.

Oncolys BioPharma Inc. - Filing #7342826

Concept 2023-01-01 to
2023-12-31
Notes - Segment information, etc.
Notes - Segment information, etc.
Description of amortization of goodwill or unamortized balance of goodwill not allocated to reportable segments
【報告セグメントごとののれんの償却額及び未償却残高に関する情報】当社は、創薬事業の単一セグメントであるため、記載を省略しております。 

Talk to a Data Expert

Have a question? We'll get back to you promptly.